Maximal benefit of integrelin platelet IIB/IIIa blockade 6–24 hours after therapy: Results of the IMPACT-II trial
Mark C.G. Horrigan, James E. Tcheng, Robert M. Califf, Michael Kitt, Todd Lorenz, Kristina Sigmon, A.Michael Lincoff, Eric J. TopolVolume:
27
Year:
1996
Language:
english
DOI:
10.1016/s0735-1097(96)80414-1
File:
PDF, 178 KB
english, 1996